Disclaimer: This article is for informational purposes only and does not constitute medical advice. These statements have not been evaluated by the Food and Drug Administration. Purisaki Berberine Patches are not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any new supplement, especially if you have existing health conditions or take prescription medications. Individual results may vary. TotalHealthRD.com is not affiliated with UAB BeWell EU or the Purisaki brand.
By TotalHealthRD.com Editorial Team
Quick Answer: Purisaki Berberine Patches are a transdermal botanical wellness patch produced by UAB BeWell EU (Lithuania) and sold online with pricing starting at $60.57 for a single pack. The formula includes berberine extract, fucoxanthin, pomegranate oil, green tea extract, and additional botanicals — however, the brand does not publicly disclose milligram dosages for any ingredient. The 60-day refund window comes with a 14-day full-refund cutoff and customer-paid return shipping. This report covers what was independently verified, where disclosure gaps exist, and what the research actually says about the core ingredient.
What Is Purisaki Berberine Patches?
Purisaki Berberine Patches are an adhesive transdermal wellness patch manufactured and sold by UAB BeWell EU, a company registered in Vilnius, Lithuania. The product is positioned as a plant-based daily support patch intended to complement mindful eating habits and wellness routines. According to the brand's official product page, users apply one patch to clean, dry skin on the upper arm, shoulder, or back for eight hours as part of a morning routine.
The patch format is the central marketing proposition. Rather than a capsule that passes through digestion, the brand positions transdermal delivery as a more convenient, stomach-friendly alternative. The company notes that manufacturing and fulfillment occur from warehouses in China, with delivery to the United States typically taking four to fourteen business days via EMS or DHL.
Purisaki is distinct from pharmaceutical transdermal patches — it is sold as a dietary supplement, not a drug. The brand's own on-site disclaimer states: “This botanical wellness patch is not a medicine or medical device and is not intended to diagnose, treat, or prevent any disease.” That framing matters when evaluating what the product is and what the research on its ingredients can and cannot say about it.
Who This Is For
Based on the brand's positioning and ingredient profile, Purisaki Berberine Patches are marketed toward adults interested in incorporating botanical support into an existing wellness routine — particularly those who prefer a simple application format over daily capsules, or those who experience stomach discomfort with oral supplements.
The product may be a reasonable consideration for adults who have researched berberine as a compound independently, are comfortable with the uncertainty that comes from undisclosed ingredient dosages, and understand that a transdermal consumer patch is a categorically different delivery mechanism than the oral berberine tested in clinical research. Those who want a supplement with transparent milligram dosages should understand that information is not currently available publicly for this product.
Who This Is NOT For
Purisaki Berberine Patches are not appropriate for several groups without explicit medical clearance first. Berberine, the primary active ingredient, has a documented interaction profile with prescription drug classes that is clinically meaningful.
Anyone taking anticoagulant or antiplatelet medications — including warfarin, apixaban, rivaroxaban, or clopidogrel — should not add berberine in any form without consulting their prescribing physician. Berberine inhibits CYP2C9 and P-glycoprotein, which can alter blood levels of warfarin and some direct oral anticoagulants. Changes in anticoagulant exposure can increase bleeding risk.
Anyone taking diabetes medications — particularly insulin, sulfonylureas, or metformin — faces additive blood glucose-lowering effects from berberine. Pharmacokinetic research has documented that berberine can increase metformin blood levels when the two are combined. Without monitoring, hypoglycemia is a real risk.
Anyone taking CYP3A4-metabolized statins such as simvastatin or atorvastatin should discuss berberine use with their physician. Berberine inhibits CYP3A4 and can increase statin blood levels, raising the risk of dose-dependent muscle side effects.
Additionally, the brand's own Terms of Service advise against use during pregnancy or nursing, and recommend consulting a healthcare professional before use for anyone with existing medical conditions. Pediatric and adolescent use is not indicated.
A complete drug interaction review is available in the companion Berberine Safety Guide on this site.
How Purisaki Berberine Patches Work — The Mechanism Claim
The brand positions the patch format as delivering botanical ingredients gradually through the skin over an eight-hour wear period, framing this as a steadier alternative to the absorption spike-and-drop pattern associated with oral capsules. The product's three-layer construction — a breathable comfort layer, a protective outer layer using biodegradable material, and a botanical core layer — is described in the product listing as the delivery system.
The primary active ingredient, berberine, has been studied in human clinical trials primarily in oral form. The mechanism most frequently cited in the research literature involves berberine's activation of AMP-activated protein kinase (AMPK), an enzyme involved in energy metabolism regulation. In oral supplementation studies, berberine at doses of 1,000 mg per day or more has been associated with modest but statistically significant effects on body weight, BMI, and waist circumference across multiple meta-analyses of randomized controlled trials.
The critical distinction that most competitor content on this topic ignores: the clinical research on oral berberine was conducted using oral supplementation at disclosed dosages — typically 500 mg to 1,500 mg per day. Purisaki delivers berberine transdermally through a consumer adhesive patch, and does not disclose the milligram amount per patch. Whether a consumer adhesive patch delivers a physiologically relevant quantity of berberine is a separate question that the existing oral research literature does not answer. For a deeper look at the mechanism and research context, see How Berberine Works: AMPK, Metabolism, and the Research.
What We Verified
This section documents what the TotalHealthRD.com editorial team independently confirmed before writing this review. Verification was completed May 14, 2026.
Pricing confirmed: Single pack $60.57. Two-pack total $60.56 (approximately $30.28 per pack). Three-pack total $81.70 (approximately $27.23 per pack). Four-pack total $90.80 (approximately $22.70 per pack). Entry-level “from $34.99” pricing displayed on product page.
Refund policy reviewed: 60-day return window from delivery. Full refund available only within the first 14 days of receipt. Returns initiated between 15 and 60 days may incur additional fees per the brand's published Terms of Service. Shipping costs are non-refundable. Return shipping is the customer's responsibility. A return merchandise authorization code must be obtained from support before sending any item back — the brand will not accept returns sent to its office address.
Company identity confirmed: UAB BeWell EU, Gynėjų St. 4-333, LT-01109 Vilnius, Lithuania. Company registration number 305788600. This is the legal operator behind the Purisaki brand name. Products ship from warehouses in China.
Contact information confirmed: US phone +1 (850) 389-0125 | UK +44 208 089 1401 | [email protected] | Contact form at trypurisaki.com/contact.
Ingredient list cross-referenced with marketing copy: The brand lists Berberine Extract, Fucoxanthin Extract, Pomegranate Oil (Punicic Acid Extract), Green Tea Extract, African Mango Extract, Vitamin C, B1, and B3 as active ingredients, plus “9 more natural ingredients” that are not named on the publicly available product page. No milligram dosages are disclosed anywhere in publicly available materials. No Supplement Facts panel with quantified amounts was accessible for this review. This is a meaningful disclosure gap for any consumer or clinician trying to evaluate the product's actual dose relative to clinical research.
FDA disclaimer confirmed on product page: “This botanical wellness patch is not a medicine or medical device and is not intended to diagnose, treat, or prevent any disease.”
What could not be verified: Any per-ingredient milligram dosage. Third-party testing or COA availability. GMP certification status. The identity of the nine additional unnamed ingredients.
The Ingredient Disclosure Gap — Why It Matters
Most competitor reviews of Purisaki either ignore the dosage disclosure issue or fabricate specific milligram figures that do not appear anywhere in the brand's published materials. This section explains why the absence of a public Supplement Facts panel is worth understanding before purchasing any supplement — not just this one.
Clinical research on berberine is almost entirely conducted at specific, disclosed oral doses — typically 500 mg, 1,000 mg, or 1,500 mg daily. The meaningful metabolic effects documented in meta-analyses of randomized controlled trials are associated with doses above 1,000 mg per day for periods of eight weeks or more, according to a 2022 review of 18 studies published findings summarized by the National Center for Complementary and Integrative Health. A product that does not disclose its dosage cannot be evaluated against that research framework. The dose is the variable that makes research findings applicable or inapplicable to any specific product.
This is not a criticism unique to Purisaki — many patch-format supplements in this category share this disclosure gap. It is, however, information a consumer making a $60-per-pack purchase decision deserves to have explicitly stated rather than quietly omitted. Before purchasing, anyone who wants to make an evidence-informed decision should contact the brand directly and ask for the Supplement Facts panel or COA, and should discuss the ingredient list with their healthcare provider. The full research context for each listed ingredient is covered in Berberine Research 2026: What the Studies Actually Show.
Pricing and Policies
Pricing as verified May 2026 from the official product page:
Single pack: $60.57 (40% discount applied from a listed $60.58 reference price). Two-pack: $60.56 total ($30.28 per pack, listed as 50% off). Three-pack: $81.70 total ($27.23 per pack, listed as 64% off). Four-pack: $90.80 total ($22.70 per pack, listed as 70% off). The brand also displays a “from $34.99” starting price on the product page; final pricing is confirmed at checkout and may reflect subscription pricing or current promotions.
The brand operates a subscription option. Subscription cancellation requests must be submitted via the contact form at trypurisaki.com/contact or by emailing [email protected]. Cancellations take effect from the following month unless the current month's item has not yet shipped, in which case cancellation and refund can be processed for that month.
Refund terms bear reading carefully. The 60-day return window is real, but the full refund window is 14 days from receipt. After 14 days, additional fees may apply under Section 6.2 of the brand's Terms of Service. Shipping costs paid at the time of purchase are non-refundable. Return shipping is at the customer's expense. Any free products included in a promotional order must be returned with the paid items for a full refund. Returns require an RMA code from support — items sent without this code will not be accepted.
Viral Term Disambiguation: “Nature's Ozempic”
Berberine supplements, including Purisaki, are sometimes marketed against the backdrop of “nature's Ozempic” — a social media framing that gained traction in 2023 and continues to circulate. This comparison deserves direct clarification because it circulates widely enough to influence purchase decisions.
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) are FDA-approved prescription medications with large-scale clinical trial data demonstrating significant weight reduction. Berberine is a plant alkaloid classified as a dietary supplement in the United States, not a pharmaceutical drug. The two compounds operate through different mechanisms, are tested under different regulatory frameworks, and have categorically different evidence bases. Describing berberine as equivalent to a GLP-1 medication is not supported by the clinical literature. The comparison is a marketing convenience, not a pharmacological fact.
Purisaki's own product page does not make GLP-1 comparisons. The brand uses structure/function language about “supporting balance” and “complementing mindful lifestyle choices.” That framing is appropriately conservative.
Frequently Asked Questions
Does Purisaki Berberine Patches really work?
Purisaki is positioned by its manufacturer as a botanical wellness patch that supports daily balance — not as a clinically tested treatment. Berberine has a well-documented research profile in oral supplementation. Milligram dosages in the Purisaki patch are not publicly disclosed, so the product cannot be directly evaluated against that research. Individual results vary. This product is not intended to diagnose, treat, cure, or prevent any disease.
How much does Purisaki Berberine Patches cost?
Single pack: $60.57. Two-pack: $60.56 total. Three-pack: $81.70 total. Four-pack: $90.80 total, as verified from the official site in May 2026. Final pricing shown at checkout reflects any current promotions.
What is the return policy for Purisaki Berberine Patches?
60-day return window from delivery. Full refund within 14 days of receipt; additional fees may apply for returns initiated between 15 and 60 days. Shipping costs are non-refundable. Customer pays return shipping. Must contact support for an RMA code before sending any return.
Are Purisaki Berberine Patches safe to use?
The brand describes the formula as containing natural ingredients for daily use, and advises consulting a healthcare provider before use if pregnant, nursing, or taking medications. Berberine as a compound has significant drug interaction potential via CYP enzyme inhibition. Anyone on anticoagulants, diabetes medications, or CYP3A4-metabolized statins should discuss with their physician before use. For a complete interaction overview, see the Berberine Safety Guide.
Who makes Purisaki Berberine Patches?
UAB BeWell EU, Gynėjų St. 4-333, LT-01109 Vilnius, Lithuania (Company reg. no. 305788600). Products ship from China. Contact: [email protected] | US: +1 (850) 389-0125.
Final Assessment
Purisaki Berberine Patches present a legitimate transdermal format for a well-researched botanical compound — berberine — backed by a company with verifiable registration details, a real refund policy, and appropriate FDA disclaimer language on the product page. Those are meaningful legitimacy signals in a category full of brands that don't provide them.
The material limitation is the absence of a publicly available Supplement Facts panel with milligram dosages. Without that data, no independent analyst, dietitian, or pharmacist can evaluate whether the patch delivers a physiologically meaningful dose of berberine or any other ingredient. That gap also makes it impossible to apply the published oral berberine research to this product directly. The clinical literature on berberine's metabolic effects is real and reasonably robust — but it was generated from oral supplementation at specific doses, not from consumer adhesive patches with undisclosed quantities.
The 60-day return window offers a reasonable consumer protection mechanism, with the important caveat that full refunds are limited to the first 14 days and return shipping costs are not covered by the brand. Anyone considering a multi-pack purchase should understand that timeline before committing to a larger order.
For those researching how berberine works mechanistically, see How Berberine Works: AMPK, Metabolism, and the Research. For the clinical evidence base, see Berberine Research 2026: What the Studies Actually Show. For drug interaction guidance relevant to anyone on prescription medications, the Berberine Safety Guide is the appropriate starting point before any purchase decision. To see how the Purisaki patch format compares to oral berberine options, see Berberine Patch vs Capsule vs Dihydroberberine: 2026 Guide.
Disclaimer: This article is for informational purposes only. These statements have not been evaluated by the Food and Drug Administration. Purisaki Berberine Patches are not intended to diagnose, treat, cure, or prevent any disease. The information on this page does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition or supplement use. Individual results may vary. TotalHealthRD.com may receive compensation for purchases made through links on this page, disclosed in accordance with FTC guidelines.